Griseofulvin was the first systemic agent used to treat onychomycosis on a widespread basis. The newer oral agents (itraconazole, terbinafine and fluconazole) have been found to be more effective than griseofulvin and the duration of active therapy is also shorter with the more recently introduced antimycotics.151,152 Moreover, when griseofulvin is used to treat dermatophyte toenail onychomycosis, relapse rates may be higher (40-60%)129 than with the newer oral antifungal agents.33,153-156
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.